tiprankstipranks
Advertisement
Advertisement
Pasithea Therapeutics: Buy Rating on Differentiated PAS-004, 2026 Clinical Catalysts, and Strengthened Cash Runway
PremiumRatingsPasithea Therapeutics: Buy Rating on Differentiated PAS-004, 2026 Clinical Catalysts, and Strengthened Cash Runway
4M ago
Pasithea Therapeutics provides updated timeline on PAS-004 programs
Premium
The Fly
Pasithea Therapeutics provides updated timeline on PAS-004 programs
4M ago
Pasithea Therapeutics Regains Nasdaq Compliance
Premium
Company Announcements
Pasithea Therapeutics Regains Nasdaq Compliance
5M ago
3 Penny Stocks to Watch Now, 11/27/25
PremiumMarket News3 Penny Stocks to Watch Now, 11/27/25
5M ago
Pasithea Therapeutics Reports Positive Phase 1 Data for PAS-004
Premium
Company Announcements
Pasithea Therapeutics Reports Positive Phase 1 Data for PAS-004
5M ago
Pasithea Therapeutics announces $1M award by ALS Association
Premium
The Fly
Pasithea Therapeutics announces $1M award by ALS Association
5M ago
Pasithea Therapeutics announces interim data from PAS-004 trial
PremiumThe FlyPasithea Therapeutics announces interim data from PAS-004 trial
6M ago
Pasithea announces activation of trial site at UAB for study of PAS-004
Premium
The Fly
Pasithea announces activation of trial site at UAB for study of PAS-004
6M ago
Pasithea Therapeutics Opens New Trial Site for PAS-004
Premium
Company Announcements
Pasithea Therapeutics Opens New Trial Site for PAS-004
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100